Identification and Functional Study of Osteosarcoma Metastasis Marker Genes

Overview

Journal Oncol Lett

Specialty Oncology

Date 2015 Dec 2

PMID 26622763

Citations 2

Authors

Rui Shi

Juan Li

Fan Tang

Y I Luo

Chong-Qi Tu

Affiliations

Soon will be listed here.

Abstract

To date, osteosarcoma metastasis genes, which are key for accurate initial diagnosis of the disease, have not been well identified. In the present study, osteosarcoma samples with and without metastasis were collected from 31 patients. Specific complementary DNA subtraction techniques were used to identify the osteosarcoma metastasis transcripts, which are responsible for the metastasis of osteosarcoma. The specific differentially expressed transcripts were identified by Basic Local Alignment Search Tool analysis and the results were validated by immunoblotting. Specifically, ezrin and β4 integrin were employed as markers to detect osteosarcoma metastasis in the initial stages. The results of the present study indicated that the two transcripts, ezrin and β4 integrin, were highly expressed in patients with osteosarcoma metastasis, and concluded that these were osteosarcoma metastasis genes. These results indicate that β4 integrin and/or ezrin may be used as a novel marker for the detection of osteosarcoma metastasis in the initial stages.

Citing Articles

Disabled homolog 2 interactive protein functions as a tumor suppressor in osteosarcoma cells.

He J, Huang S, Lin Z, Zhang J, Su J, Ji W Oncol Lett. 2018; 16(1):703-712.

PMID: 29963135 PMC: 6019915. DOI: 10.3892/ol.2018.8776.

Identification of the miRNA-mRNA regulatory network of small cell osteosarcoma based on RNA-seq.

Xie L, Liao Y, Shen L, Hu F, Yu S, Zhou Y Oncotarget. 2017; 8(26):42525-42536.

PMID: 28477009 PMC: 5522085. DOI: 10.18632/oncotarget.17208.

References

Nikolopoulos S, Blaikie P, Yoshioka T, Guo W, Giancotti F . Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell. 2004; 6(5):471-83. DOI: 10.1016/j.ccr.2004.09.029. View

Yu Y, Khan J, Khanna C, Helman L, Meltzer P, Merlino G . Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004; 10(2):175-81. DOI: 10.1038/nm966. View

Hood J, Cheresh D . Role of integrins in cell invasion and migration. Nat Rev Cancer. 2003; 2(2):91-100. DOI: 10.1038/nrc727. View

Dorfman H, Czerniak B . Bone cancers. Cancer. 1995; 75(1 Suppl):203-10. DOI: 10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v. View

Heldin C, Miyazono K, Ten Dijke P . TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997; 390(6659):465-71. DOI: 10.1038/37284. View

Gould K, BRETSCHER A, Esch F, Hunter T . cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J. 1989; 8(13):4133-42. PMC: 401598. DOI: 10.1002/j.1460-2075.1989.tb08598.x. View

Bretscher A, Edwards K, Fehon R . ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol. 2002; 3(8):586-99. DOI: 10.1038/nrm882. View

Anderson D, Maraskovsky E, Billingsley W, Dougall W, Tometsko M, Roux E . A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997; 390(6656):175-9. DOI: 10.1038/36593. View

Harris M, Gieser P, Goorin A, Ayala A, Shochat S, Ferguson W . Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. J Clin Oncol. 1998; 16(11):3641-8. DOI: 10.1200/JCO.1998.16.11.3641. View

10.

Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C . Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 2001; 61(9):3750-9. View

11.

Modi W, Dean M, Seuanez H, Mukaida N, Matsushima K, OBrien S . Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily. Hum Genet. 1990; 84(2):185-7. DOI: 10.1007/BF00208938. View

12.

Wan X, Kim S, Guenther L, Mendoza A, Briggs J, Yeung C . Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin. Oncogene. 2009; 28(38):3401-11. PMC: 2753583. DOI: 10.1038/onc.2009.206. View

13.

. ERM proteins: from cellular architecture to cell signaling. Biol Cell. 2000; 92(5):305-16. DOI: 10.1016/s0248-4900(00)01078-9. View

14.

Green R, Krause J, Briggs A, Maricic T, Stenzel U, Kircher M . A draft sequence of the Neandertal genome. Science. 2010; 328(5979):710-722. PMC: 5100745. DOI: 10.1126/science.1188021. View

15.

Standal T, Borset M, Sundan A . Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol. 2004; 26(3):179-84. View

16.

Mariotti A, Kedeshian P, Dans M, Curatola A, Gagnoux-Palacios L, Giancotti F . EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol. 2001; 155(3):447-58. PMC: 2150849. DOI: 10.1083/jcb.200105017. View

17.

Wong B, Rho J, Arron J, Robinson E, Orlinick J, Chao M . TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 1997; 272(40):25190-4. DOI: 10.1074/jbc.272.40.25190. View

18.

Ottaviani G, Jaffe N . The epidemiology of osteosarcoma. Cancer Treat Res. 2010; 152:3-13. DOI: 10.1007/978-1-4419-0284-9_1. View

19.

Aplin A, Howe A, Juliano R . Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol. 1999; 11(6):737-44. DOI: 10.1016/s0955-0674(99)00045-9. View

20.

Hynes R . Integrins: bidirectional, allosteric signaling machines. Cell. 2002; 110(6):673-87. DOI: 10.1016/s0092-8674(02)00971-6. View